Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U5E small nuclear 6, pseudogene (RNU5E-6P)** is classified as a small nuclear RNA (snRNA) pseudogene, meaning it is a non-functional genomic locus related to snRNAs, specifically those of the U5E snRNA family, and does not encode a functional product. Pseudogenes like RNU5E-6P are typically non-coding and are not transcribed into active RNA molecules or proteins involved in cellular functions. Unlike canonical snRNAs such as U5 or U6, which are components of the spliceosome involved in pre-mRNA splicing, pseudogenes such as RNU5E-6P have no known biological function, do not participate in cellular pathways, and are not considered drug targets or disease-associated molecules. Pseudogenes are sometimes annotated in reference genomes due to their sequence similarity to functional genes, but there is no evidence that RNU5E-6P contributes to any recognized biological role or is implicated in human disease or therapy[1][4]. **Key context:** - This entry is *not* a therapeutic target, enzyme, receptor, or other molecule of functional interest in current biomedical research[1][4]. - The “pseudogene” designation explicitly means a non-functional, typically non-transcribed genomic remnant. - There is no authoritative evidence linking RNU5E-6P to pathways, drugs, biomarkers, or disease mechanisms in the scientific literature. - Many snRNA pseudogenes are annotated in genetic databases—for example, the U6 and U5 families—but typically only their functional counterparts (like U5 snRNA itself) are implicated in splicing or disease processes[3][4]. - If you intended to query a functional small nuclear RNA (e.g., U5, U6), please clarify the specific gene or RNA name, as pseudogenes such as RNU5E-6P do not have active molecular or therapeutic roles. **Conclusion:** RNU5E-6P is a pseudogene and not a therapeutic or biological target. This makes “is_incorrect: true” appropriate if your interest is in active molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5E small nuclear 6, pseudogene (RNU5E-6P).